Joseph Priestley Society Presents “Industrial/Academic Research Partnerships: How Research Is Funded Today”

Electron-beam lithography system

Electron-beam lithography system. Perkin-Elmer AEBLE 150. Applera/Perkin-Elmer Collection, CHF Collections.

Date: November 13, 2014
Time: 10:30 a.m. to 2:00 p.m.

315 Chestnut Street
Philadelphia, PA 19106

Event Type: Open to the Public
Fee: $25
RSVP Online: Registration Required

In a time when the amount of governmental grant money for basic research continues to shrink, how can a university maintain its vibrant research presence? In a time when shareholder pressure for “bottom-line results” squeezes research budgets for industrial concerns, how can a company dependent upon science to solve problems and create new materials keep the momentum of research going? This panel of experienced researchers and administrators will discuss these issues in depth.

Watching remotely? Visit to view the live webcast of the symposium (12:00 p.m. to 2:00 p.m.).

Coming in person? Use the registration links above.

  About the Event

The Joseph Priestley Society (JPS) lecture series explores topics in science, technology, and industry through professional networking receptions and lectures by industry leaders.

More information

For more information about this event, please contact Sarah Reisert, awards program manager, at 215.873.8263 or

Boyle Society members receive complimentary admission!

Robert Boyle Society members: To register yourself and up to three guests free of charge, please contact Nancy Vonada, manager of events and donor relations, at 215.873.8226 or

  Event Schedule

Thursday, November 13, 2014

10:30 a.m.

Networking Reception and Brunch

12:00 p.m.


 Speaker Biographies

placeholder image

Magid Abou-Gharbia

Magid Abou-Gharbia

Magid Abou-Gharbia is currently the associate dean for research, Laura H. Carnell Professor of Medicinal Chemistry, and director of the Moulder Center for Drug Discovery Research at the School of Pharmacy, Temple University. He is responsible for setting and implementing research strategies to promote the school’s research and entrepreneurial enterprise. Before joining Temple University in 2008, Magid spent 26 years at Wyeth Pharmaceuticals where he was senior vice president and head of chemical and screening services. In this capacity he was responsible for overseeing and directing Wyeth’s worldwide chemistry and screening research efforts of 500 scientists at four U.S. research facilities and 150 chemists in Hyderabad, India, in support of drug discovery in the therapeutic areas of neuroscience, inflammation, women’s health/bone, oncology, and cardiovascular/metabolic diseases.

Over the years Abou-Gharbia’s group research efforts have contributed to the discovery of eight marketed drugs and many compounds currently under clinical evaluation. He has also worked with organizations around the globe in an effort to establish and implement modern paradigms for drug discovery and to promote biomedical research. Among his recent contributions in the Middle East is the establishment of the Qatar Biomedical Research Institute, which promotes medicinal chemistry and drug discovery research at four major educational institutions in the region.

He holds a BS in pharmacy and pharmaceutical sciences and an MS in medicinal chemistry from the School of Pharmacy, Cairo University. He holds a PhD from the University of Pennsylvania and did a two-year NIH postdoctoral fellowship at the Temple University Medical School and Department of Chemistry.

Marc Donohue

Marc D. Donohue

Marc D. Donohue

Marc Donohue is a professor of chemical and biomolecular engineering at Johns Hopkins University. He has served for 12 years as department chair of chemical engineering and also for 12 years as vice dean for research in engineering. He is past chair of the Board of Directors of the Council for Chemical Research. His research interests are in the thermodynamics of fluid phase behavior, diffusion, and adsorption, and in the psychology of leadership.

Kate Stebe

Kathleen J. Stebe

Kathleen J. Stebe

Kathleen Stebe became the deputy dean for research in the School of Engineering and Applied Science at the University of Pennsylvania in July 2012. In 2008 she joined the faculty at the University of Pennsylvania as the Richer and Elizabeth M. Goodwin Professor of Engineering and Applied Science, and from 2008 to 2012 she also served as the department chair of chemical and biomolecular engineering. Before transferring to Penn, she was part of the Department of Chemical Engineering at Johns Hopkins University (JHU), where she rose through the ranks to become a professor and to serve as the department chair.

Stebe’s research focuses on capillary phenomena, including how anisotropic particles interact and assemble at interfaces, in complex fluids, including liquid crystals and lipid bilayers. She is an expert in interfacial flows, with particular emphasis on how surfactants can be used to direct interfacial flows and how surfactants alter drop breakup modes. Other aspects of her research address dynamic surface tension, rheology of protein-laden interfaces, and the design of interfaces and bounding surfaces for biological and materials applications.
Stebe has been a fellow at the Radcliffe Institute for Advanced Studies, and has received the Robert S. Pond Excellence in Teaching Award at JHU and the Frenkiel Award from the Division of Fluid Dynamics of the American Physical Society (APS). She was also named a fellow of the APS.

Stebe received a BA in economics (magna cum laude) from the City College of New York (CCNY) and a PhD in chemical engineering at the Levich Institute, also at CCNY, under the guidance of Charles Maldarelli. Thereafter, she spent a postdoctoral year in Compiègne, France, working with Dominique Barthès Biesel.

Tom Tritton

Thomas R. Tritton

Thomas R. Tritton

Thomas R. Tritton is a senior fellow at the Chemical Heritage Foundation and a visiting scholar at the University of Pennsylvania. He is former president of Haverford College and former president and CEO of the Chemical Heritage Foundation. Before joining CHF he was president-in-residence at the Harvard Graduate School of Education. He was also a professor of pharmacology for 12 years each at Yale University and the University of Vermont (UVM). At UVM he served as deputy director of the Vermont Comprehensive Cancer Center and as vice provost of the university. He is currently chair of the Board of Trustees at Ohio Wesleyan University, a member of the Corporation of Haverford College, and a member of the Boards of Directors for the Fox Chase Cancer Center, the Greater Philadelphia Life Sciences Congress, and the Center for the History of Science, Medicine, and Technology. In addition, Tritton is a scientific adviser to Sefacor, a biotechnology company developing cures for brain cancer, and a partner in CALICO, a consulting firm that provides advice to nonprofit organizations.

Need Meeting Space?

CHF’s state-of-the-art conference center is in Philadelphia’s beautiful historic district.

Sensing Change

See your environment with fresh eyes through this online exhibit.

Support CHF

Help us preserve and share the history of chemistry and related sciences. Make a tax-deductible tax-deductible gift online.